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ABSTRACT
Background: The Affordable Care Act (ACA) aimed at making health care
affordable and accessible including the use of preventive care services. To achieve these
aims, the ACA expanded Medicaid coverage to population with income below 138% of
FPL and removed cost-sharing when using preventive care services recommended by the
USPSTF. This study tried to assess the impact of these provisions on the rate of
mammography and Pap tests among women. Methods: Data was obtained from the
Medical Expenditure Panel Survey - Household Component MEPS-HC. A difference-indifference design was used to determine the effect of Medicaid eligibility expansion on
the outcomes and a counterfactual analysis was used to determine the effect of removing
cost-sharing from preventive care services on the outcomes. Results: The difference-indifference estimate show that likelihood of utilizing mammograms did not change
significantly among low-income women after the implementation of the Medicaid
expansion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test decreased
(coefficient -0.0615, t-statistics -2.76), and Medicaid enrollment has increased
significantly among low-income women living in expansion states (coefficient 0.0889
with t-value of 3.68). The counterfactual analysis show that the utilization of
mammogram and pap test did not improve following the ACA. Conclusion: The ACA
was associated with increased Medicaid enrollment but did not yield near-term
improvement in use of mammography and Pap tests among women. Factors beyond
health insurance coverage may be important in determining the likelihood of obtaining
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these screening procedures and policy makers should try to identify other barriers to
cancer screening services utilization among the low-income women in the USA.
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CHAPTER 1
INTRODUCTION

In March 2010, the Patient Protection and Affordable Care Act, often shortened to
the Affordable Care Act (ACA) was signed into law. Major aims of the ACA were to
make health care affordable and to increase the use of preventive care services, and in
turn, reduce costly events from poorly or unmanaged chronic conditions. To achieve
these aims, the ACA expanded Medicaid coverage to include the entire population aged
18-64 with income below 138% of the federal poverty line and removed cost-sharing
when using preventive care services recommended by the US Preventive Services Task
Force (USPSTF) (1). The percentage of American women who receive mammograms
and pap tests has been suboptimal in the years before the ACA (2). It has been
documented in the literature that cost-sharing or health insurance are associated with the
use of medical services including preventive care services (3–15). This study tried to
assess the impact of these ACA’s provisions on mammograms and Pap tests rates among
women.
1.1 BACKGROUND
Mammography
Breast cancer is the most commonly diagnosed cancer among American women,
besides skin cancer (16). Death rates from breast cancer are higher than those for any
other cancer, besides lung cancer. In 2018, there will be an estimated 266,120 new cases
1

of invasive breast cancer diagnosed in women and 41,400 deaths in the US (16). Women
who appropriately screen for breast cancer are likely to receive more timely diagnosis
and treatment (16–21). Mammography is the most widely used screening modality for the
detection of breast cancer. Results from randomized controlled trials and observational
studies found that mammography reduces the risk of dying from breast cancer (19–21).
However, mammograms do have risks. Sometimes mammograms find false positives that
carry risks including pain, anxiety, and other side effects. Experts make trade-offs
between benefits and risks when making recommendations about who should be
screened. Establishing age-appropriate guidelines for screening women for breast cancer
is debated by experts in the medical field. There is evidence that mammogram decrease
breast cancer mortality among women aged 50-69 but the benefit of mammography for
women aged 40-49 years is uncertain (22,23). The American cancer society recommends
beginning annual mammography at the age of 40. This was updated in 2015 to increase
the starting age to 45. The 2002 guidelines by the US Preventive Services Task Force
(USPSTF) suggests mammography for women of age 40 years or more, with or without
clinical breast examination, every 1 to 2 years. This was updated in 2009 which
recommends mammogram for women aged 50-75 every two years. The ACA utilizes the
2002 US Preventive Services Task Force (USPSTF) recommendation on breast cancer
(24).
Pap tests
Cervical cancer incidence rates declined by half between 1975 and 2014 due to
the widespread uptake of the Pap test. However, declines have slowed down in recent
years. In 2018, there will be an estimated 13,240 new cases of invasive cervical cancer
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diagnosed in women and 4,170 deaths in the US (16). Many women getting regular pap
tests, which can find cervical precancer before it turns into cancer, have reduced the
number of cases of cervical cancer and the number of deaths from cervical cancer
(25,26). Similar to mammograms, pap tests sometimes come with harm when abnormal
results lead to vaginal bleeding, pain, infection, and anxiety. However, the USPSTF
concludes that for women aged 21 to 65 years, there is high certainty that the benefits of
screening with pap test every three years substantially outweigh the harms (27). The
American cancer society and the USPSTF recommend pap tests for women aged 21-65
every 3 years or if aged 30-65 pap test combined with HPV screening is recommended
every 5 years.
Despite evidence that screening greatly improves health outcomes, rates of
mammography and pap test screenings remained suboptimal in the United States in the
years preceding the ACA (2). The percentage of American women who receive
mammograms has remained steady whereas the percentage of women who receive Pap
tests has declined slightly. In 2015, 65.3% of women aged 40 and older had a
mammogram within two years, while 69% of women aged 18 and older had a pap test
within three years (2). Within the low-income women, 54.9% received mammography
while 60% received pap test (2). The National Cancer Institute's (NCI) goals include
increasing the proportion of women who get regular mammograms to 80%, and similar
goals have been issued for pap tests.
There are disparities in breast and cervical cancer screenings, diagnosis, and
outcomes in terms of income, education, race, and health insurance (16,28–36). For
example, black and Hispanic women and women without private insurance are less likely
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than white women and women with private insurance to obtain high-quality
mammography screening (33). A study showed that black and Hispanic women continue
to be diagnosed at a later stage of breast cancer compared to white women (34).
Regardless of race, people with lower income status have higher cancer death rates than
those with higher income (16). Women who are uninsured or low-income are less likely
to receive possibly lifesaving recommended cancer screenings (35). Despite the CDC
funded Breast and Cervical Cancer Early Detection Program that provides screening and
diagnostic services for uninsured and low-income women, evidence shows limited
success reaching the targeted population (37).
Health Insurance and Cost-sharing
Health insurance is critical to whether people get necessary medical care, when
and where they get their care, and finally how healthy they are (38). Evidence shows that
a lack of health insurance coverage is one of the reasons people skip care, particularly
preventive screenings (3–14). For example, a study found that disparities in cancer
screenings by health insurance status and type of insurance exist among U.S. adults (3).
Other previous observational studies show strong associations between health insurance
coverage and the receipt of mammography and pap tests (10–13,33). Also, some
evidence exists that show cost-sharing reduces the use of recommended procedures such
as preventive interventions and cancer screenings (15).
ACA provisions: (A) Medicaid Expansion
To reduce the number of the uninsured population and improve access to care
among the low-income population, the ACA expanded the coverage of Medicaid to
include the entire population aged 18-64 with income below 138% of federal poverty
4

line. States participation in Medicaid expansion became optional after the national
federation of independent business vs Sebelius supreme court ruling in 2012 (39). The
Medicaid expansion took effect for most states on January 2014. As of September 2018,
34 states have adopted Medicaid expansion, 3 states are considering expansion, and 14
states did not expand Medicaid (40). In 2013, the poor population had the highest level of
un-insurance (41). As most uninsured population before the ACA were low-income,
Medicaid coverage expansion has the potential to improve access for low-income
population to high quality health care including mammography and Pap tests (41,42). In
2016, there were 11 million individuals newly eligible in Medicaid as a result of the
Medicaid expansion according to a report from Centers for Medicare & Medicaid
Services (CMS) (43).
ACA provisions: (B) Removing Cost-Sharing for preventive care Services
To increase the use of preventive care services, the ACA required private insurers
and Medicare to cover all preventive services recommended by US Preventive Services
Task Force (USPSTF) with a rating of A (strongly recommended) or B (recommended)
without any cost sharing. The policy became effective on September 23, 2010 for private
health insurers and on January 2011 for Medicare. Medicaid was not required to cover
preventive services without cost-sharing. However, in 2013, incentives were offered to
state Medicaid to cover preventive services for adults with no cost sharing.
1.2 PURPOSE AND SIGNIFICANCE OF THE STUDY
Assessing the impact of the ACA’s provisions on health cost, health care
utilization, and access is critical to provide timely feedback on this important health
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reform, especially when uncertainty continuous to surround it at both the state and federal
levels. The ACA contained several strategies aimed at reducing health cost and uninsurance rate as well as increasing access to needed health care including cancer
preventive screenings among low-income population. However, to date, there is limited
evidence as to the effectiveness of the policy in improving the uptake of mammograms
and Pap tests among women.
Given the previously discussed advantages of mammography and Pap tests in
reducing the risk of cancer mortality, the suboptimal screening rates, and the established
association between health coverage and utilization, this study tried to assess the impact
of the ACA on mammography and Pap test rates among women in general as well as
low-income women in particular. The findings from this study will provide scientific
evidence that will add to or confirm the existing body of knowledge on this topic and it
will advance our understanding of the potentials of the Medicaid expansion and the
removal of cost-sharing in improving the delivery of healthcare.
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CHAPTER 2
LITERATURE REVIEW

2.1 THEORETICAL FRAMEWORK
Because mammograms and Pap tests are effective in identifying possible cancer
cases and can help improve quality and length of life, women will demand these services.
Real demand is when women’s desire to have good health is backed up by their ability
and willingness to pay. In economics, the Demand Theory suggests that demand for
health services (i.e. mammograms and pap tests) is a function of price paid for the
services, prices of other complementary and substitute services and products, income of
household, underlying preference structure, and risk-attitude (44). Preference structure
and risk-attitudes may be modified by education, health insurance, health campaigns,
marital status, smoking status, regular exercise, alcohol use, etc. The ACA provisions
such as expanding Medicaid coverage and removing cost-sharing will affect variables
from the demand function such as prices and health insurance status.
When health care services are not purchased directly from providers but rather
obtained at subsidized prices due to health insurance, the out-of-pocket prices faced by
consumers are typically much lower than the market price. This distinction is often
described under "ex-post moral hazard". In this case, moral hazard is considered an
efficient tool in increasing demand for preventive care that results in reduced future cost.
The term “Moral Hazard” was first introduced into the modern academic literature by
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Kenneth J Arrow in 1963 when he defined moral hazard in health insurance as the idea
that “medical insurance increases the demand for medical care” (45). The notion of moral
hazard was highlighted in the landmark RAND Health Insurance Experiment (RAND
HIE) conducted between 1974-1977 (14). The RAND experiment randomly assigned a
representative sample of families with adults under the age of 62 to health insurance
plans with different levels of cost sharing, ranging from full coverage (zero cost sharing)
to plans that provided almost no coverage. The experiment showed that when faced with
cost-sharing, people reduce the use of all types of health care services particularly
preventive care. Before the RAND experiment, the general idea was that health care
utilization is affected only by health need. The experiment proved that seeking health is
sensitive to price and therefore obtaining health insurance increase demand for health
care.
Mammography and Pap tests receipt were shown in a number of observational
studies to be associated with health insurance coverage (10–13,33). For example, a study
found that women without private insurance are less likely than women with private
insurance to obtain high-quality mammography screening (46). Another study found that
women who are uninsured are less likely to receive possibly lifesaving recommended
cancer screenings (35). A study examined the role of health insurance on pap test and
mammography utilization among immigrant and nonimmigrant women and found that
women took the screenings as long as they had health insurance or a regular source of
care (10). Another study used longitudinal survey data to examine the effect of insurance
coverage on the rates of mammography and pap testing, and found that the rates
decreased with an increasing occurrences of un-insurance (11). Preventive services
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utilization was found to be associated with having health insurance, as insurance
coverage increased the receipt of mammography and pap test increased (12). A study
examined the effect of Medicaid expansion of 1996 on taking pap smear test, and found
that previously uninsured women took the test after becoming eligible (13).
2.2 MEDICAID EXPANSION
Evidence from Pre-ACA
In 2006, the state of Massachusetts passed a health care reform law that contained
Medicaid expansion and subsidized private health insurance. The components of this
legislation have been considered by many to serve as the blueprint for the ACA of 2010.
Several quasi-experimental studies found the Massachusetts health reform to be
associated with improved access and utilization of health care services among adults in
general (47–49) and low-income population in particular (50–52). A study on the
Massachusetts reform, anticipated large increases in coverage rates and access to care for
low-income childless adults in the states expanding Medicaid under the ACA (50).
In 2008, in the state of Oregon, a group of uninsured low-income adults were
selected randomly by lottery to enroll for the Medicaid program. This created a chance to
conduct a randomized control trial (RCT) that would examine the impact of expanding
health coverage on access, utilization, and health outcomes among poor population. The
Oregon Health Insurance Experiment (OHIE) showed increased health services use
including mammography and pap tests (53). Another study took advantage of the
randomized controlled trial setting to investigate the impact of the coverage expansion on
cancer preventive screenings and found that the Medicaid expansion provided access to
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important care and screenings that could help to detect cancers earlier especially among
women (54).
Evidence from Post-ACA
Overall, 20 million uninsured adults gained insurance under the ACA (55). 11
million were newly eligible in Medicaid as a result of the Medicaid coverage expansion
(43). In 2016, Medicaid enrollment increased by 36% from 2014 among the states that
had expanded Medicaid, compared with less than 12% in the non-expansion states (56).
The reduction in un-insurance rate was larger in expansion states compared to nonexpansion states (57). Low-income population, the group targeted by the policy,
experienced coverage rate increases (58–60). A recent study found that low-income
population who have previously lacked coverage, experienced increased coverage by a
7.5 percent in the sates that expanded Medicaid (60). In addition to improvements in
coverage rate, improvements have been observed in health care access, utilization,
affordability, and preventive care following the 2014 Medicaid expansion (61–69).
However, some studies found no significant impact of the expansion on some certain
outcomes such as length-of-stay, mortality, self-reported health, and doctor visits (57,70–
72). In subgroup analysis, early findings of the ACA indicate that there has been
significant impact among the poor, low-educated adults, those living in rural areas, and
racial and ethnic minorities live in Medicaid expansion states (41,73–78). However, a
study suggests that large gaps remain in access and affordability, particularly for lowincome adults (79). Disparities in cancer screening by race and socioeconomic status may
widen as women remain uninsured in non-expansion states and others gain coverage
(80,81). As for mammography and pap tests, early post-ACA evidence gave mixed
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results, particularly among low-income adults. Cole et al. (82) compared changes among
federally funded community health centers in expansion versus non-expansion states
from 2011 to 2014. Those centers were likely to be particularly affected by this
expansion because many of their patients were uninsured and low income. Their study
results found that, compared to centers in non-expansion states, centers in expansion
states had significant improvements in for pap tests use (82). However, other studies did
not find significant improvement from the Medicaid expansion on mammography and
pap tests. For example, Simon et al. (83) examined data of low-income adults from 2010
to 2015 and found that the expansion increased access to certain types of preventive care
but no significant impact was found on mammography and pap tests (83). Miller et al.
(57) looked at the first two years of the expansion and found no significant changes in the
rates of mammography. A recent study by Cawley et al. (84) observed the impact of
Medicaid expansion three years after the expansion and found no detectable impact on
pap tests or mammograms.
2.3 REMOVAL OF COST-SHARING
The removal of cost-sharing for recommended preventive care services was
believed to increase the use of those services. Evidence exists that show cost-sharing
reduces the use of recommended procedures such as preventive interventions and cancer
screenings (15). A study used data from 1995 to 2003 to examined the cost-sharing
waiver on elderly women, anticipated that eliminating cost-sharing under the ACA may
be an effective strategy for increasing preventive services use (85). Post-ACA, studies
reported mixed results on the impact of removing cost-sharing on mammography and pap
test (85–94). Hong et al. (94) evaluated the impact of removing cost-sharing in being up-
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to-date on mammography and Pap tests and found decreased rates of being up-to-date on
women’s cancer screening among those with private insurance. Other studies examined
the initial impact of the policy on privately insured women and found no change in
mammography and Pap tests after the ACA (88–90). Other studies, however, yielded
positive results. For example, a recent study found the policy to be associated with
improved mammography and Pap tests among Hispanics and African Americans (95).
Also, a study that assessed the policy from a health system level found that removing
cost-sharing under the ACA to be associated with increased screening volumes among
women age 50-74 (93). Studies that looked at Medicare population gave mixed results
regarding mammography utilization. For example, Jensen et al (92) found minimal
change in mammography among older women, while other studies found a statistically
significant increase in mammography uptake after the ACA among elderly women
(86,87).
After this extensive literature review, it remains uncertain what would be the
impact of the health coverage expansion through Medicaid and the removal of costsharing on mammograms and Pap tests. Based on the demand theory in economics, I
hypothesized that Medicaid coverage expansion and the removal of cost-sharing when
using preventive services will be associated with improved rates of mammograms and
Pap tests.
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CHAPTER 3
METHODS

3.1 DATA SOURCE
Data for this study was obtained from the Medical Expenditure Panel Survey Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys of
families and individuals, their medical providers (doctors, hospitals, pharmacies, etc.),
and employers across the United States. MEPS collects data on the specific health
services that Americans use, how frequently they use them, the cost of these services, and
how they are paid for, as well as data on the cost, scope, and breadth of health insurance
held by and available to U.S. workers. This study utilizes the Household
Component (HC) of the MEPS, which collects data from a sample of families and
individuals in selected communities across the United States, drawn from a nationally
representative subsample of households that participated in the prior year's National
Health Interview Survey (conducted by the National Center for Health Statistics). During
the household interviews, MEPS collects detailed information for each person in the
household on the following: demographic characteristics, health conditions, health status,
use of medical services, charges and source of payments, access to care, satisfaction with
care, health insurance coverage, income, and employment. MEPS contains the data on
health care utilization, health insurance status, coverage source, and cost that are required
to answer the research question.
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3.2 DESIGN
Difference-in-Differences design (Medicaid expansion study)
This analytic design tests a comparison of the change in trends of outcomes
before and after Medicaid expansion across expansion states vs non-expansion states,
controlling for other covariates representing risk attitudes and preference structure. The
treatment group includes women living in Medicaid expansion states and control group
includes women living in non-expansion states. Only the states that expanded Medicaid
between January 2014 and January 2016 were included in the treatment group (appendix
A). The states that already provided Medicaid or similar coverage to low-income adults
before 2014 were excluded (District of Columbia, Delaware, Massachusetts, New York,
and Vermont) (see appendix A). For estimating the DID parameters, pre-ACA period is
defined as the years 2012-13 and the post period is defined as the years 2015-16.
The following multivariate linear regression was estimated to find the effect of the
policy change on the outcome variables, the likelihood of receiving mammography and
pap smears:
Yist = β0 + β1 Treatment + β2 Post + β3 (Treatment*Post) + βx Covariates + Ɛ
Where “Yist” represents outcome for individual “i” living in state “s” at time ‘t”.
β0 is the baseline average. The term “Treatment” is a dummy variable equal to 1 if the
individual resides in a treatment group (expansion state). β1 is the difference between the
two groups pre-intervention. The term “Post” is a dummy variable equal to 1 if the time
is after the Medicaid expansion. β2 is the time trend in control group. The term
“Treatment*Post” is an interaction term of intervention and time, β3 represents the
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difference-in-differences estimator capturing the effect of Medicaid expansion.
Covariates are added to the model to control for preference structure and risk attitudes.
This regression model, in theory, will be able to indicate the effect of treatment if
the intervention and control groups are identical at the baseline or show similar pattern of
change over the years. In the real world, the intervention and control groups in preintervention period are never identical and therefore differences between the groups need
to be explicitly considered and incorporated in the analysis. The effect of program change
can be estimated if the assumption of similar pattern of changes over the years in preintervention years may be assumed in post-intervention periods as well. This is known as
the “parallel assumption” in DID analysis. Since the parallel assumption must hold for an
unbiased DID estimator, we can test the parallel movements or trend in the outcomes
prior to policy change in treatment and control groups over a number of years. To assess
the validity of this assumption, we regressed each outcome for the years 2005 to 2013 on
variables indicating years, state expansion status and an interaction term of year and state
expansion status. If the coefficient of the interaction term is not statistically different
from zero, it implies that the rate of change of the dependent variables is not different
between the intervention and control areas confirming the parallel movement of the
outcome over the years prior to the implementation of the intervention.
Counter-factual design (Cost-sharing study)
We used a counterfactual analysis to determine the impact of ACA on the
preventive screenings rate. Counterfactual analysis helps to understand what would have
happened in post-ACA year if ACA was not there. This was done by estimating a model
that examines determinants of the dependent variable for pre-ACA (year 2009). Then, the
15

estimated model was used to predict the dependent variable using post-ACA
characteristics of individuals (the determinants from the model) (year 2016). The model
basically works as pseudo control group allowing estimation of the utilization of
screenings if ACA policy changes were absent. Effect of ACA is then estimated as: rate
of dependent variable post-ACA minus the predicted rate of dependent variable in the
same post-ACA year using counterfactual (that there was no ACA in that year). We
chose determinants that we believe may modify the demand for the screening tests and
the potential variables incorporated in the model are: age, race, income, education,
marital status, region, health insurance type, physical activity, smoking status,
comorbidity, routine medical checkup, metropolitan area, out-of-pocket expenses, and the
availability of a usual source of care. It is important to note that there are few
determinants of cancer screenings are likely to change due to the introduction of ACA,
implying that incorporating these variables for the post-ACA sample to define the
counterfactual will underestimate the effect of ACA because some of these determinants
that are affected by ACA will pick-up some of the changes happened due to the
implementation of ACA. Most important variables likely to change due to the
implementation of ACA are coverage rate of health insurance and types of insurance
people have. To ensure that the counterfactual estimates are not biased, insurance type
and coverage rates should be kept the same in the post-ACA year as it was in the preACA year. This was done through adjusting the sampling weights so that pre- and postACA insurance coverage and types of insurance coverage are the same.
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3.3 OUTCOME
The outcomes are the self-reported receipt of mammogram and Pap tests. For
each preventive service, respondents were asked “About how long has it been since you
had this mammogram/Pap test?” with possible responses being “within past year,”
“within past 2 years,” etc. In accordance with screening guidelines, a dummy variable
was created for mammogram utilization equal to 1 if the test was taken within 1 to 2
years, and a dummy variable for pap test utilization equals to 1 if the test was taken
within 1 to 3 years.
We controlled for variables that we believe may modify the preference structure
and risk attitude of women in the sample. According to the Demand Theory, demand for
health services is a function of prices of the services, household income, preference
structure, and risk-attitude. We chose covariates that may modify the preference structure
and risk attitude, making individuals more risk averse and therefore more likely to
undergo screening tests. The covariates chosen are: age, race, marital status, education,
health insurance status, comorbidity, physical activity, smoking status, and metropolitan
area (Table 3.1).
3.4 SAMPLE
Medicaid expansion sample
Figure 3.1 shows the inclusion and exclusion criteria for the study samples that
assessed the impact of the Medicaid expansion. From the 2012-16 MEPS datasets, the
sample extracted consists of nonelderly low-income women living in the U.S. Women
living in states that already provided Medicaid or similar coverage to low-income adults
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before ACA’s Medicaid expansion in 2014 were excluded from the analysis (District of
Columbia, Delaware, Massachusetts, New York, and Vermont). Women aged 65 years or
older were excluded because they are eligible for Medicare. Women belonging to lowincome households, as defined by the ACA, were selected for the analysis as this group is
eligible for participation in Medicaid after the policy change, if they were not enrolled in
Medicaid at the time of expansion. In accordance with screening guidelines, the
mammography cohort will include women aged 40-64 and the Pap test cohort will
include women aged 21-64. Women with concurrent or past diagnoses with breast or
cervical cancer were excluded from the analysis to focus on utilization of screening
services for preventive or early diagnosis purposes (Figure 3.1).
Cost-sharing sample
Figure 3.2 shows the inclusion and exclusion criteria for the study samples that
assessed the impact the removal of cost-sharing for preventive care services. From the
MEPS 2009 and 2016 data set, there were two separate cohorts for mammography and
pap test. In accordance with the USPSTF screening guidelines, the mammography cohort
will include women aged 40 and older and the pap test cohort will include women aged
21-65. Although the recent USPSTF guidelines regarding breast cancer recommends
mammography for women aged 50-74 every 2 years, our mammography cohort included
women aged 40 and older because the ACA still utilizes the 2002 guidelines. Women
with concurrent or past diagnoses with breast or cervical cancer were excluded from the
analysis to focus on screening for preventive purposes (Figure 3.2).
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3.5 STATISTICAL ANALYSIS
Difference-in-Differences analysis
First, univariate analysis was done to produce baseline descriptive statistics of the
low-income women living in treatment (expansion states) and control groups (nonexpansion states). Second, we tested the parallel trends assumption across expansion and
non-expansion states by regressing each outcome for the years 2005 to 2013 on variables
indicating years, state expansion status and an interaction term of year and state
expansion status. Third, a difference-in-differences regression model was estimated by
linear ordinary least squares. A linear model was chosen to allow a direct interpretation
of the coefficients and avoid interpretive issues inherent to interaction terms in nonlinear
models (97,98). The key parameter of interest from the DID model was the parameter
associated with the interaction between treatment and time. This parameter represents the
estimated difference in outcome rates between pre- and post-policy change, across states
that were and were not affected by the policy change. Differences were considered
statistically significant if P-value of t-statistics <0.05. Finally, a sub-group analyses was
done using linear regression and univariate analysis to explain the effect of different
demographics, socioeconomics, and geographic determinants on screening use. All
analyses were carried out using STATA software version 14 (2015; Stata 14.0 Statistical
Software, College Station, TX, USA). The analyses accounted for probability weighting
in the MEPS (99,100) to obtain national estimates of effects of the policy change.
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Counter-factual analysis
Univariate analyses will be done to produce descriptive statistics of women’s
characteristics before and after the implementation of ACA in the sample. The main
statistical modeling will be based on a regression equation explaining the variability of
the dependent variables in pre-ACA period using a number of determinants or
explanatory variables. The equations estimated can be written as:
𝑌𝑖0 = 𝛽0 + ∑ 𝛽𝑗 𝑋𝑖𝑗0, where Yio is the value of dependent variable for individual i
for the pre-ACA year 0 and [Xj] is a set of potential determinants of Y. This estimated
model was then used to predict the dependent variable for the post-ACA years using the
values of determinants in the post-ACA data set. In other words, we have predicted the
values of Y for the post-ACA year t using the estimates of b from the pre-ACA year.
̂0 + ∑ 𝛽̂𝑗 𝑋𝑖𝑗𝑡
𝑌𝑖𝑡 = 𝛽
The estimated coefficients b obtained for pre-ACA year will be used to predict the
values of dependent variable for individuals in post-ACA year, the year t. Another
regression model was estimated to predict the values of Y in post-ACA year using postACA data. The effect of ACA will be estimated as the value of dependent variable in the
post-ACA year minus the predicted value of the dependent variable in the post-ACA year
using the regression model obtained using pre-ACA year (the counterfactual). A positive
difference means that women in post-ACA used more mammography and pap tests
compared to pre-ACA year given various determinants of the dependent variable. Since a
number of potential determinants of dependent variable may be affected by the
introduction of ACA-triggered changes, these variables should be kept constant at the
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pre-ACA level. These variables are related with insurance coverage and types of
insurance under which the individuals are covered. We have kept the values of these
determinants constant in relative terms at the pre-ACA level by changing the sampling
weights proportionately. To assess the diagnostic/predictive accuracy of our logistic
model, we used the area under the ROC curve measure. Third, we regressed the
difference of the dependent variable, the estimated effect of ACA adoption, on some
population characteristics to examine how different individual characteristics affect the
outcome. Differences were considered statistically significant if P-value of the t-statistics
<0.05. All statistical analysis will be carried out using STATA software version 14
(2015; Stata 14.0 Statistical Software, College Station, TX, USA The analyses accounted
for probability weighting in the MEPS (99,100).
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Table 3.1 List of covariates (controls)
Variable

Categorization

Age

>= 18 (health costs cohort)
21-64 (pap test cohort)
>= 40 (mammogram cohort)
Low
Middle
High
Any private
Public only
Uninsured
White
Black
Other
Some school
High school
College
Married
Widowed
Divorced
Separated
Never Married
Northeast
Midwest
South
West

Income

Health Insurance type

Race

Education

Marital status

Region

Usual source of care
Physical activity
Smoking status
Comorbidity

Routine medical checkup

Available
Not available
Exercise frequently
Does not exercise frequently
Smoker
Non-smoker
0 chronic disease
1 chronic disease
2 chronic diseases or more
Within last year
More than a year ago
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Figure 3.1 Inclusion and exclusion criteria (Medicaid expansion)
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Figure 3.2 Inclusion and exclusion criteria (Cost-sharing)
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CHAPTER 4
MANUSCRIPT I

THE IMPACT OF MEDICAID EXPANSION UNDER THE ACA ON
MAMMOGRAPHY AND PAP TESTS AMONG LOW-INCOME
WOMEN1

Abstract
Background: The ACA expanded the coverage of Medicaid to include entire population
with income below 138% of federal poverty line which took effect on January 1, 2014. It
remains unclear whether this policy change has improved access to and utilization of
health care, particularly use of mammography and Pap tests among poor women.
Methods: We used a difference-in-difference design to estimate the impact of Medicaid
expansion under the ACA on mammography and Pap tests utilization among low-income
women. In the DID model, expansion states are the treatment group and non-expansion
states are the control group. The years 2012-13 are the pre-expansion period and 2015-16
are the post-expansion period for the purpose of estimating the DID parameters. Results:
The difference-in-difference estimate show that likelihood of utilizing mammograms did
not change significantly among low-income women after the implementation of the
Medicaid expansion (DID coefficient -0.0476 with t-statistics at -1.26), Pap test
decreased (coefficient -0.0615, t-statistics -2.76), and Medicaid enrollment has increased
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significantly among low-income women living in expansion states (coefficient 0.0889
with t-value of 3.68). Conclusion: Expansion of Medicaid was associated with increased
Medicaid enrollment but did not yield near-term improvement in use of mammography
and Pap tests among low-income women. Factors beyond health insurance coverage may
be important in determining the likelihood of obtaining these screening procedures and
policy makers should try to identify other barriers to cancer screening services utilization
among the low-income women in the USA.

Introduction
Breast cancer is the most commonly diagnosed cancer among American women,
and the second most common cause of death from cancer besides lung cancer (101,102).
Cervical cancer incidence rates declined by half between 1975 and 2014 due to the
widespread uptake of the Pap test, but declines have slowed down in recent years
(101,102). Evidence show that women who appropriately screen for breast and cervical
cancer are likely to receive more timely diagnosis and treatment (16–21,25,26) and yet,
rates of mammography and Pap test screenings remained suboptimal in the United States
(103). Low-income women utilize less screenings than middle or high income women. In
2015, 54.9% of low-income women received mammography while 60% received Pap test
(103). The National Cancer Institute's goals include increasing the proportion of women
who get regular mammograms to 80%, and similar goals have been issued for Pap tests.
There are several possible reasons for the suboptimal screening rates, among which lack
of health insurance coverage is considered an important one. There is evidence that health
insurance is associated with uptake of mammogram and Pap test use (10–13,33).

26

The Patient Protection and Affordable Care Act of 2010 (ACA) expanded the
coverage of Medicaid to include the entire population aged 18-64 with income below
138% of the federal poverty line (104). Since uninsured adults were more likely to be
low-income, Medicaid expansion has the potential to improve access to health care
among this poor segment of the population (105–107). Under ACA, participation of
States in Medicaid expansion became optional after a supreme court ruling in 2012 (39)
but many states decided to participate in Medicaid expansion immediately after the policy
change and by September 2015, majority of the states have expanded Medicaid. As of
September 2018, 34 states have adopted Medicaid expansion, 3 states are considering
expanding, and 14 states did not expand. Appendix A lists the states with Medicaid
expansion status as of September 2018 (40).
Previous evidence gave mixed results regarding the impact of Medicaid expansion
on utilization of mammography and Pap tests (108–111). Since no conclusive evidence is
available, this study made an attempt to understand the effect of Medicaid expansion on
probability of obtaining screening tests like mammography and Pap tests among lowincome women. Since the study is using nationally representative data set, the results
would indicate the effects of policy change for the country as a whole. Nationally
representative data will also allow identification of factor affecting utilization rates.
Methods
Data source
Data for this study was obtained from the Medical Expenditure Panel Survey Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys which
collects data from a sample of families and individuals in selected communities across

27

the United States, drawn from a nationally representative subsample of households. The
MEPS contains the data on health care utilization, health insurance status, and coverage
source that are required to answer the research question. The combined average response
rate for the years 2012-2016 was 50.7% (112).
Sample
From the 2012-16 MEPS datasets, the sample extracted consists of nonelderly
low-income women living in the U.S. Women living in states that already provided
Medicaid or similar coverage to low-income adults before ACA’s Medicaid expansion in
2014 were excluded from the analysis (District of Columbia, Delaware, Massachusetts,
New York, and Vermont). Women aged 65 years or older were excluded because they are
eligible for Medicare. Women belonging to low-income households, as defined by the
ACA, were selected for the analysis as this group is eligible for participation in Medicaid
after the policy change, if they were not enrolled in Medicaid at the time of expansion. In
accordance with screening guidelines, the mammography cohort will include women
aged 40-64 and the Pap test cohort will include women aged 21-64. Women with
concurrent or past diagnoses with breast or cervical cancer were excluded from the
analysis to focus on utilization of screening services for preventive or early diagnosis
purposes.
Design
This study used a difference-in-difference (DID) design in a regression
framework. This analytic design tests a comparison of the change in trends of outcomes
before and after Medicaid expansion across expansion states vs non-expansion states,
controlling for other covariates representing risk attitudes and preference structure. The
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treatment group includes women living in Medicaid expansion states and control group
includes women living in non-expansion states. Only the states that expanded Medicaid
between January 2014 and January 2016 were included in the treatment group (appendix
A). The states that already provided Medicaid or similar coverage to low-income adults
before 2014 were excluded (District of Columbia, Delaware, Massachusetts, New York,
and Vermont) (see appendix A). For estimating the DID parameters, pre-ACA period is
defined as the years 2012-13 and the post period is defined as the years 2015-16.
The following multivariate linear regression was estimated to find the effect of the
policy change on the outcome variables, the likelihood of receiving mammography and
pap smears:
Yist = β0 + β1 Treatment + β2 Post + β3 (Treatment*Post) + βx Covariates + Ɛ
Where “Yist” represents outcome for individual “i” living in state “s” at time ‘t”.
β0 is the baseline average. The term “Treatment” is a dummy variable equal to 1 if the
individual resides in a treatment group (expansion state). β1 is the difference between the
two groups pre-intervention. The term “Post” is a dummy variable equal to 1 if the time
is after the Medicaid expansion. β2 is the time trend in control group. The term
“Treatment*Post” is an interaction term of intervention and time, β3 represents the
difference-in-differences estimator capturing the effect of Medicaid expansion.
Covariates are added to the model to control for preference structure and risk attitudes.
This regression model, in theory, will be able to indicate the effect of treatment if
the intervention and control groups are identical at the baseline or show similar pattern of
change over the years. In the real world, the intervention and control groups in preintervention period are never identical and therefore differences between the groups need
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to be explicitly considered and incorporated in the analysis. The effect of program change
can be estimated if the assumption of similar pattern of changes over the years in preintervention years may be assumed in post-intervention periods as well. This is known as
the “parallel assumption” in DID analysis. Since the parallel assumption must hold for an
unbiased DID estimator, we can test the parallel movements or trend in the outcomes
prior to policy change in treatment and control groups over a number of years. To assess
the validity of this assumption, we regressed each outcome for the years 2005 to 2013 on
variables indicating years, state expansion status and an interaction term of year and state
expansion status. If the coefficient of the interaction term is not statistically different
from zero, it implies that the rate of change of the dependent variables is not different
between the intervention and control areas confirming the parallel movement of the
outcome over the years prior to the implementation of the intervention.
Outcome
The outcomes for this study are the self-reported receipt of mammogram, Pap test,
and Medicaid enrollment status. For the preventive services, respondents were asked
“About how long has it been since you had this mammogram/Pap test?” with possible
responses being “within past year,” “within past 2 years,” etc. In accordance with
screening guidelines, a dummy variable was created for mammogram utilization equal to
1 if the test was taken within 1 to 2 years, and a dummy variable for pap test utilization
equals to 1 if the test was taken within 1 to 3 years.
Covariates
We controlled for variables that we believe may modify the preference structure
and risk attitude of women in the sample. According to the Demand Theory, demand for
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health services is a function of prices of the services, household income, preference
structure, and risk-attitude. We chose covariates that may modify the preference structure
and risk attitude, making individuals more risk averse and therefore more likely to
undergo screening tests. The covariates chosen are: age, race, marital status, education,
health insurance status, comorbidity, physical activity, smoking status, and metropolitan
area.
Statistical analysis
First, univariate analysis was done to produce baseline descriptive statistics of the
low-income women living in treatment (expansion states) and control groups (nonexpansion states). Second, we tested the parallel trends assumption across expansion and
non-expansion states by regressing each outcome for the years 2005 to 2013 on variables
indicating years, state expansion status and an interaction term of year and state
expansion status. Third, a difference-in-differences regression model was estimated by
linear ordinary least squares. A linear model was chosen to allow a direct interpretation
of the coefficients and avoid interpretive issues inherent to interaction terms in nonlinear
models (97,98). The key parameter of interest from the DID model was the parameter
associated with the interaction between treatment and time. This parameter represents the
estimated difference in outcome rates between pre- and post-policy change, across states
that were and were not affected by the policy change. Differences were considered
statistically significant if P-value of t-statistics <0.05. Finally, a sub-group analyses was
done using linear regression and univariate analysis to explain the effect of different
demographics, socioeconomics, and geographic determinants on screening use. All
analyses were carried out using STATA software version 14 (2015; Stata 14.0 Statistical
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Software, College Station, TX, USA). The analyses accounted for probability weighting
in the MEPS (99,100) to obtain national estimates of effects of the policy change.
Results
Table 4.1 shows the baseline characteristics of the nonelderly low-income women
living in expansion and non-expansion states. Majority of the low-income women were
white in both expansion and non-expansion states, however, more black women lived in
non-expansion states (37.38%) compared to expansion states (23.94%). In both treatment
and control groups, majority of low-income women did not have a college degree (Table
4.1). In expansion and non-expansion states, majority of low-income women had public
health insurance, however, more women had public health insurance in expansion states
(53.22%) as compared to non-expansion states (41.67%). Majority of the low-income
women lived in metropolitan areas in both treatment and control groups (Table 4.1).
Women in treatment and control groups had a similar age mean (37). Therefore, states
deciding to expand Medicaid were different from the states deciding not to expand in
terms of percent of low income population not white, level of coverage of public
insurance program and percent of poor women living in metro areas.
Figure 4.1 shows trends in mammogram and Pap tests rates across expansion and
non-expansion state for the years 2005 to 2013. Results from the regression that tested
the parallel assumption of the time trend of outcome variable show that the slope of the
trend functions were similar for these two groups of states prior to the implementation of
the ACA policy on Medicaid expansion (Appendix B).
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Table 4.2 reports the results from the univariate analysis that examined screening
rates among women living in expansion states post-ACA by different sub-groups. The
results show majority of low-income women who used mammograms and Pap tests were
high-income (76.20%, 85.73%) high-educated (72.93%, 83.88%), Black (73.61%,
87.91%), with private insurance (74.20%, 84.13%), living in metropolitan areas (71.36%,
83.13%), and reported having a usual source of care (74.52%, 83.92%), for
mammograms and Pap tests respectively.
Table 4.3 reports the results from the difference-in-difference adjusted regression
model. The DID estimates indicate that the probability of enrolling to Medicaid has
increased significantly among the low-income women after the implementation of
Medicaid expansion (estimated coefficient 0.0889 with t-value 3.68). The DID estimates
indicate that the probability of utilizing mammograms did not change significantly
among low-income women after the implementation of the Medicaid expansion
(estimated coefficient -0.0476 with t-value -1.26). For the Pap tests, the DID estimate
indicate that the probability of utilizing the test has decreased significantly among lowincome women after the implementation of the Medicaid expansion compared to nonexpansion states (estimated coefficient -0.0615, t-value -2.76).
Table 4.4 shows the results on the likelihood of receiving mammograms and Pap
tests among low-income women using a number of possible determinants of utilization of
the screening tests. The sub-group analysis shows that poor women with higher age were
more likely to receive mammograms (estimated coefficient 0.0102, t-value 4.16) and less
likely to receive Pap tests (estimated coefficient -0.174, t-value -5.08). Black women
were more likely to receive mammograms (estimated coefficient 0.0812, t-value 3.87)
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and Pap tests (estimated coefficient 0.0686, t-value 5.75) as compared to white women.
The table also indicates that women from other minority population groups were less
likely to receive Pap tests as compared to white women (estimated coefficient -0.0646, tvalue -2.90). Women with a college degree were more likely to receive mammograms
(estimated coefficient 0.0605, t-value 2.56) and women who were divorced were less
likely to receive mammograms (coefficient -0.0875, t-value -3.47) and Pap tests
(coefficient -0.0385, t-value -2.00) compared to married women. Women with public
health insurance were less likely than those with private insurance to receive
mammograms (estimated coefficient -0.0654, t-value -2.55) but no difference was
detected for Pap test use (estimated coefficient -0.00391, t-value -0.26). Uninsured
women were less likely to receive mammograms (estimated coefficient -0.250, t-value 8.97) and Pap tests (estimated coefficient -0.110, t-value -6.61). Women living in nonmetropolitan areas were less likely than those in metropolitan areas to receive Pap tests
(estimated coefficient -0.0615, t-value -3.41) but no difference was detected for
mammogram use (estimated coefficient -0.0489, t-value -1.62). Women who reported not
having a usual source of care were less likely to receive mammograms (estimated
coefficient -0.141, t-value -4.03) and Pap tests (estimated coefficient -0.0562, t-value 3.02) compared to those who have a usual source of care. Non-smokers were more likely
to receive mammograms (estimated coefficient 0.0706, t-value 3.15) and Pap tests
(estimated coefficient 0.0446, t-value 3.30) as compared to smokers. Women with two or
more chronic diseases were more likely to receive mammograms (estimated coefficient
0.133, t-value 5.22) but no differences were detected for Pap test use (estimated
coefficient 0.0251, t-value 1.58).
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Discussion
The affordable care act (ACA) expanded Medicaid eligibility coverage to the
entire low-income population in order to improve access and utilization among this
disadvantage section of the population. In the years before the ACA, rates of
mammograms and Pap tests showed declining trends among women and more so among
poor women (103). This study examined the impact of expanding health coverage
through Medicaid on the rates of mammograms and Pap tests among poor women. The
difference-in-difference (DID) estimates indicate that Medicaid enrollment has increased
significantly among low-income women after the implementation of the Medicaid
expansion (see Table 4.3). This is a proximate measure of success of ACA in terms of
providing coverage to poor women through Medicaid. Other studies also found increased
Medicaid enrollment in expansion states compared to non-expansion states (113).
However, the increase in Medicaid enrollment among low-income women did not
translate into increased rates of mammograms or Pap test utilization. Other studies also
found little impact of Medicaid expansion on mammography and Pap tests rates
(84,113,114).
Although the difference-in-differences estimate did not show increase in
mammograms and Pap tests rates, low-income women living in expansion states used
more screenings than their counterparts in non-expansion states (Table 4.3). Historically,
mortality rates of breast and cervical cancer were lower in the states that elected to
expand Medicaid compared to those who elected not to expand (115). We compared
cancer burden in expansion vs non-expansion states in pre and post-ACA using data from
the National Cancer Institute (NCI) and found that women in expansion states had lower
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mortality rates compared to women in non-expansion states (breast cancer: 20.13 vs
20.50; and cervical cancer: 1.97 vs 2.41) per 100,000 resident (115). A previous study
found that Southeastern states without Medicaid expansion tended to have higher cancer
and lower screening rates and therefore disparities in cancer screening that already
disfavor states with high cancer rates may widen in states that have chosen not to expand
Medicaid (116).
A number of possible explanations can be advanced for this lack of improvements
in mammograms and Pap tests rates among the low-income women despite gaining
insurance coverage through Medicaid. First, our analysis show that low-income women
with private insurance were more likely to receive mammograms than those with public
insurance (Table 4.4). Also, in expansion states, the proportion of low-income women
with private insurance used more mammograms and Pap tests than those with public
insurance (Table 4.2). Another study also found that women with employer-based
insurance/Medicare were more likely to get breast and cervical cancer screenings (117).
According to a survey conducted by the National Center for Health Statistics, only two
out of three primary care physicians surveyed in 2011 were willing to accept new
Medicaid patients (118). Our analysis showed that women who reported having a usual
source of care were more likely to receive mammograms and Pap tests than those without
a usual source of care (Table 4.4). In expansion states, the proportion of low-income
women who have a usual source of care used more mammograms and Pap tests than their
counterparts (Table 4.2). Therefore, the type of insurance and the availability of a usual
source of care may have the most effect on access and receiving theses screenings.
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Second, there are previous studies that found that Medicaid expansion was
effective in improving rates of certain preventive services such as glucose testing,
cholesterol testing, and annual check-up, but not for cancer screenings (108,109). This is
probably because mammograms and Pap tests come with side effects that may discourage
women in accepting the tests (119–122). Mammograms show relative high false
positivity which creates significant loss of wellbeing and quality of life including pain
and suffering, anxiety, and other side effects. Similar to mammograms, Pap tests may
come with harm when abnormal results lead to vaginal bleeding, pain, infection, and
anxiety. Physicians make trade-offs between benefits and risks when making
recommendations about who should be screened (123). Also, the guidelines for
mammograms and Pap tests were updated around the time of the ACA’s provisions. The
guidelines for mammograms were updated in 2009 to recommend mammograms for
women aged 50-75 every 2 years from the previous guidelines that recommended
screening every 1-2 years for women aged 40 or older (124). The guidelines for cervical
cancer screenings was updated in 2012 to recommend the Pap test for women aged 21-65
every three years from the previous guidelines that recommended screening annually for
women who are sexually active. These guideline changes occurred around the same time
as the expansion of Medicaid under ACA which may explain the overall decline in cancer
screenings. However, the effect of changing the recommendation guidelines is universal
across expansion and non-expansion states and therefore may not explain the lack of
effect on mammograms and Pap tests in expansion states in our difference-in-difference
design.
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Third, the results from the difference-in-difference may have been biased or
equalized because of the possibility that a significant number of poor women received
screenings through other national programs such as the CDC’s National Breast and
Cervical Cancer Early Detection Program (NBCCEDP). The program was established in
1990 to provide free and/or reduced cost mammograms and Pap tests to women with
limited incomes and those who lack health insurance. Although number of women
receiving those services through the NBCCEDP has decreased in 2015-16 compared to
2013 (125), low-income women still benefit from this program which may have negated
the impact of ACA on mammograms and Pap tests rates in our difference-differences
analysis. Between 2012 and 2017 the NBCCEDP program provided 740,108 Pap tests
and 902,751 mammograms to low-income women (125). In expansion states between
2012 and 2017 there were 441,206 Pap test provided (452 screenings per 100,000
woman) and 498,659 mammograms (511 screenings per 100,000 woman) while in nonexpansion states the rates were 398 per 100,000 woman for Pap test and 573 per 100,000
woman for mammography (125). Mammograms provided to women in non-expansion
states was about 12% higher than the rate in expansion states and the opposite is true for
Pap tests (12% lower in non-expansion states). Such differences can potentially bias the
estimation of the effect of ACA on the uptake of mammograms and Pap tests.
Fourth, our analysis showed that the majority of screenings occurred among the
high-income high-educated women while low-income women had the least utilization
rates (Table 4.2). Before the ACA, a study found low-income women were less likely to
receive possibly lifesaving recommended cancer screenings (35). A post-ACA study
examined the impact of Medicaid expansion on disparities in cancer screenings and found
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that large gaps remain in access, particularly for low-income adults (79). Our analysis
showed that disparities in terms of using mammograms and Pap tests remained and may
have actually become worse. This possibly implies that other factors beyond the
insurance coverage provided through Medicaid should be examined in order to reduce
socioeconomic disparities.
Finally, our sub-group analyses helped shed light on the likelihood of receiving
mammograms and Pap tests among low-income women using a number of possible
determinants of utilization of the screening tests. As women got older they were more
likely to receive mammograms and less likely to receive pap tests (Table 4.4). This is
expected as evidence suggests benefits from mammograms are more evident for older
women while benefits from Pap tests are more evident for younger women (126,127).
Low-income women living in metropolitan areas were more likely to receive
mammograms and Pap tests (Table 4.4). Also, in expansion states, the proportion of lowincome women living in metropolitan areas used more mammograms and Pap tests
(Table 4.2). This is expected as metropolitan areas have more medical care providers than
non-metro or rural areas. Black women were more likely than white women to receive a
Pap test (Table 4.4). Also, in expansion states, the proportion of black women used more
mammograms and Pap tests than white women (Table 4.2). Historically, black women in
the U.S. are more likely to be diagnosed and die from breast and cervical cancer than
white women, which may explain the increased use of the screenings (128).
Conclusion
Our study shows that expansion of Medicaid under the ACA was associated with
increased Medicaid enrollment but did not yield near-term improvements in the use of
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mammography and Pap tests among low-income women. Although the difference-indifferences did not show improvements in mammograms and Pap tests due to Medicaid
expansion under ACA, low-income women living in expansion states used higher level of
screenings than their counterparts in non-expansion states. In DID, lack of any positive
results is due to pattern of changes happened in screening rates in expansion and nonexpansion states. In expansion states, the increase in screening rates were either lower or
negative. Since Medicaid expansion did not affect these screening tests, policy makers
need to examine other factors that may act as barriers in improving access and utilization.
Some possible explanations for this lack of impact of the Medicaid expansion on
mammograms and Pap tests are presented in the discussion section but we have no
concrete evidence to conclusively say which factors have affected access to screening
tests adversely in the expansion states compared to non-expansion states. It is also
possible that a longer timeframe will be needed for a change to be manifested but this
study only looked at three years after the policy change. Future research on provider
availability and characteristics, insurance types, and geographical variations is warranted
for a better understanding of the use of cancer screening procedures by the poor women
in the USA.
We acknowledge some important limitations of this study. First, information
about outcomes relied on self-reported survey responses which might be subject to recall
error. However, the MEPS follow up with health providers to reduce the reporting errors
but some errors may still remain, especially for procedures and tests requiring longer
recall time frame. Second, the data used in the analysis are cross-sectional and
comparison of cross-sectional data at different years is not same as observing changes in
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the outcomes with the implementation of ACA. The study design made an attempt to
tease-out the effect of policy changes through DID and in most cases DID approach can
identify the effect of policy change even when the starting characteristics of the control
and intervention groups are significantly different. Third, since repeated cross-sectional
survey data were used, it was not possible to show the pathways of outcome variation,
i.e., the effect of ACA on Medicaid enrollment and effect of Medicaid enrollment on the
outcomes of interest. Fourth, this study examined the initial 3-year period after the ACA
Medicaid expansion provision and a longer time frame may be needed to be able to see
the effects of policy changes on outcomes. Finally, there were changes in the USPSTF
guidelines for breast cancer and cervical screening that occurred around the same time as
the ACA provisions which may have led to overall declines in cancer screening. In 2009
the guidelines for breast cancer screenings was updated to recommend biennial screening
instead of every 1-2 year screenings. Also, in 2012 the USPSTF guidelines for cervical
cancer was updated to recommend the test every 3 years instead of every year. National
programs providing these tests to poor women may have dampen the effect of the policy
change and if the national program in post-policy change years provided more emphasis
on covering screenings in non-expansion states, it can potentially offset any positive
effects of Medicaid expansion when estimated through DID modeling. In any case, this
lack of relative improvements in cancer screenings in the Medicaid expansion states
(compared to non-expansion states) is perplexing and would require supplementing the
national data with other program effects and other structural differences between these
two groups of states.
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Table 4.1 Baseline characteristics of low-income women aged 18-64, living in expansion
and non-expansion states, pre-ACA (2012-13), MEPS dataset
Characteristic

Age
Race
White
Black
Other minorities
Education
Some school
High school
College
Health insurance
Private
Public
Uninsured
Metropolitan area
Metro
Non-metro

Non-expansion
states
N= 3,729
37 (mean)

Expansion states
N= 3,459
37 (mean)

57.39
37.38
5.23

P value

0.0839
0.000

67.07
23.94
8.99
0.000

34.51
34.54
30.95

38.90
31.17
29.94

18.10
41.67
40.23

16.48
53.22
30.30

82.38
17.62

87.80
12.20

0.000

0.000
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Table 4.2 Rates of mammograms and Pap tests use in different groups in expansion
states, results univariate analysis (2012-16), MEPS dataset
Mammogram

Pap test

% in post-ACA

change

P value

% in post-ACA

change

P value

Low-income

64.69

+ 2.03

0.337

80.19

-1.71

0.151

Middle-income

70.08

- 3.14

0.178

81.05

-0.71

0.633

High-income

76.20

-3.1

0.094

85.73

-1.16

0.351

White

70.10

-0.99

0.497

81.49

-0.97

0.289

Black

73.61

-1.34

0.645

87.91

-.04

0.979

Other

69.02

+1.22

0.715

79.77

-2.36

0.251

Some school

65.23

+0.20

0.943

80.93

-0.56

0.760

High school

69.24

+1.32

0.594

79.51

+0.33

0.832

College

72.93

-2.31

0.150

83.88

-1.7

0.076

Metro

71.36

-0.87

0.496

83.13

-0.96

0.213

Nonmetro/rural

61.42

-2.12

0.610

73.33

-3.14

0.259

Private insurance

74.20

-3.49

0.015

84.13

-1.99

0.30

Public insurance

67.10

-4.03

0.122

80.86

-4.9

0.001

Uninsured

52.87

+2.04

0.597

73.72

+0.93

0.706

Available USC

74.52

-1.91

0.135

83.92

-2.08

0.012

Not Available USC

48.96

+0.83

0.80

75.64

+0.47

0.793

Table 4.3 Results from the difference-in-differences adjusted regression model,
nonelderly low-income women (2012-16), MEPS dataset
Outcome

Expansion states

Non-expansion states

Pre-ACA rate

Post-ACA rate

Pre-ACA rate

Post-ACA rate

62.66 %

64.69 %

58.87 %

61.77 %

81.90 %

80.19 %

78.80 %

79.36 %

38.10 %

52.31 %

21.12 %

25.03 %

Mammogram
Pap tests
Medicaid
enrollment
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Difference-indifferences
-0.0476
(-1.26)
-0.0615**
(-2.76)
0.0889***
(3.68)

Table 4.4 Likelihoods of receiving mammograms and Pap tests using a number of
determinants, results from adjusted linear regression model (2012-16), MEPS dataset
Determinants
Age

Mammogram
0.0102***
(4.16)

Pap tests
0.000137
(0.11)
0
(.)
-0.0789***
(-3.59)
-0.174***
(-5.08)
0
(.)
0.0686***
(5.75)
-0.0646**
(-2.90)
0
(.)
-0.00437
(-0.33)
-0.0120
(-0.85)
0
(.)
-0.0883*
(-2.47)
-0.0385*
(-2.00)
-0.00593
(-0.27)
-0.0277*
(-2.03)
0
(.)
-0.00391
(-0.26)
-0.110***
(-6.61)
0
(.)
-0.0615***
(-3.41)
0
(.)
-0.0562**
(-3.02)
0
(.)
-0.0102
(-0.92)
0
(.)
0.0446***
(3.30)
0
(.)
0.0223
(1.63)
0.0251
(1.58)

21-39
40-49
50-64
White
Black
Other minorities
Some school
High school
College
Married
Widowed
Divorced
Separated
Never Married
Private insurance
Public insurance
Uninsured
Metro area
Non-metro area
Usual source of care available
Usual source of care not available
Exercise regularly
Do not exercise regularly
Smoker
Non-smoker
No chronic diseases
1 chronic disease
+2 chronic diseases

0
(.)
-0.00818
(-0.23)
0
(.)
0.0812***
(3.87)
-0.0588
(-1.59)
0
(.)
0.0419
(1.82)
0.0605*
(2.56)
0
(.)
-0.103*
(-2.56)
-0.0875***
(-3.47)
-0.0799*
(-2.37)
-0.0749**
(-2.86)
0
(.)
-0.0654*
(-2.55)
-0.250***
(-8.97)
0
(.)
-0.0489
(-1.62)
0
(.)
-0.141***
(-4.03)
0
(.)
-0.00171
(-0.09)
0
(.)
0.0706**
(3.15)
0
(.)
0.0479
(1.68)
0.133***
(5.22)
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Figure 4.1 Trends in mammogram and Pap across expansion and non-expansion states
among low-income women, MEPS 2005-13
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CHAPTER 5
MANUSCRIPT II

THE IMPACT OF REMOVING COST SHARING UNDER THE
AFFORDABLE CARE ACT (ACA) ON MAMMOGRAPHY AND PAP
TEST USE2

Abstract
Background: The ACA required private insurers and Medicare to cover preventive
services recommended by the USPSTF without any cost sharing to improve utilization of
these services. This study tried to identify the impact of removing cost sharing on
mammography and pap test utilization rates. Methods: Counterfactual analysis was used
to predict what would have been the screening rates in post-ACA if ACA was not there.
This was done by estimating a model that examines determinants of dependent variable
for the pre-ACA year (pre-ACA year is 2009). The estimated model was then used to
predict the dependent variable for the post-ACA year using individual characteristics and
other relevant variables unlikely to be affected by ACA (post-ACA year is 2016). Effect
of ACA is defined as the difference between the values of dependent variables in postACA and the predicted values of dependent variables in the post-ACA year using
counterfactual. Results: The counterfactual analysis show that the utilization of
mammogram and pap test did not improve following the ACA. Conclusion: following

2

Alharbi, A., Khan, M., Horner, R., Brandt, H., Chapman, Cole. To be submitted to American Journal of
Preventive Medicine
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the removal of cost-sharing under the ACA, no improvement in mammography or pap
tests rate was observed. It appears that financial barrier was not an important factor in
affecting utilization of the screening tests and policy makers would have to focus on other
non-financial barriers in order to improve coverage of the tests.
Introduction
Cancer is among the leading causes of death in the United States. An estimated
41,400 deaths from invasive breast cancer and 4,170 deaths from cervical cancer will
occur in 2018 (16). Mammography and pap test screenings allow early detection of the
diseases leading to potentially successful treatment (17–20,26,129,130). Despite evidence
of screening effectiveness in improving health outcomes, rates of mammography and pap
test screenings remained suboptimal in the United States (103). The US Preventive
Services Task Force (USPSTF) recommends mammography for women aged 50-74 years
every two years, and pap test for women aged 21-65 years every three years (24).
According to the Centers for Disease Control and Prevention (CDC), in 2015, 65.3% of
women aged 40 years and older had a mammogram within previous two years, while
69% of women aged 18 years had a pap test within three years (103). Suboptimal rates of
screenings may have resulted from financial barriers women face such as cost-sharing,
the amount of money individuals required to pay when seeking medical care. There is
evidence that cost-sharing reduces the use of health services, particularly preventive
services (15,131).
The Patient Protection and Affordable Care Act (ACA) required private insurers
and Medicare to cover the preventive services recommended by US Preventive Services
Task Force (USPSTF) with a rating of A (strongly recommended) or B (recommended)
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without cost sharing. The policy became effective on September 23, 2010 for private
health insurers and on January 2011 for Medicare (132). The goal was to increase the use
of preventive services and, in turn, reduce costly events from poorly or unmanaged
chronic conditions. Previous research reported mixed results regarding the impact of
removing cost sharing on mammography and pap test utilization (85–94). As the effect of
removing cost-sharing on mammography and pap test utilization are still unclear, this
study aims to generate evidence on the impact of changes brought about by the ACA on
mammography and pap tests rates.
Methods
Data
Data for this study was obtained from the Medical Expenditure Panel Survey Household Component MEPS-HC (96). The MEPS is a set of large-scale surveys which
collects data from a sample of families and individuals in selected communities across
the United States, drawn from a nationally representative subsample of households.
MEPS contains the data on health insurance status and coverage source, utilization, and
cost that are required to answer the research question. The MEPS contains the data on
health care utilization, health insurance status, coverage source, and cost that are required
to answer the research question. The combined average response rate for the years 2009
and 2016 was 51.6% (112).
Sample
Figure 5.1 shows the inclusion and exclusion criteria for the study samples that
assessed the impact the removal of cost-sharing for preventive care services. From the
MEPS 2009 and 2016 data set, there were two separate cohorts for mammography and
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pap test. In accordance with the USPSTF screening guidelines, the mammography cohort
will include women aged 40 and older and the pap test cohort will include women aged
21-65. Although the recent USPSTF guidelines regarding breast cancer recommends
mammography for women aged 50-74 every 2 years, our mammography cohort included
women aged 40 and older because the ACA still utilizes the 2002 guidelines. Women
with concurrent or past diagnoses with breast or cervical cancer were excluded from the
analysis to focus on screening for preventive purposes (Figure 5.1).
Design
We used a counterfactual analysis to determine the impact of ACA on the
preventive screenings rate. Counterfactual analysis helps to understand what would have
happened in post-ACA year if ACA was not there. This was done by estimating a model
that examines determinants of the dependent variable for pre-ACA (year 2009). Then, the
estimated model was used to predict the dependent variable using post-ACA
characteristics of individuals (the determinants from the model) (year 2016). The model
basically works as pseudo control group allowing estimation of the utilization of
screenings if ACA policy changes were absent. Effect of ACA is then estimated as: rate
of dependent variable post-ACA minus the predicted rate of dependent variable in the
same post-ACA year using counterfactual (that there was no ACA in that year). We
chose determinants that we believe may modify the demand for the screening tests and
the potential variables incorporated in the model are: age, race, income, education,
marital status, region, health insurance type, physical activity, smoking status,
comorbidity, routine medical checkup, metropolitan area, out-of-pocket expenses, and the
availability of a usual source of care. It is important to note that there are few
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determinants of cancer screenings are likely to change due to the introduction of ACA,
implying that incorporating these variables for the post-ACA sample to define the
counterfactual will underestimate the effect of ACA because some of these determinants
that are affected by ACA will pick-up some of the changes happened due to the
implementation of ACA. Most important variables likely to change due to the
implementation of ACA are coverage rate of health insurance and types of insurance
people have. To ensure that the counterfactual estimates are not biased, insurance type
and coverage rates should be kept the same in the post-ACA year as it was in the preACA year. This was done through adjusting the sampling weights so that pre- and postACA insurance coverage and types of insurance coverage are the same. The dollar value
in the out-of-pocket variable was adjusted for inflation using MCPI with 2016 as the base
year.
Outcome
The outcomes are the self-reported receipt of mammogram and pap test as
measured in the MEPS database. For each preventive service, respondents were asked
“About how long has it been since you had this mammogram/Pap test?” with possible
responses being “within past year,” “within past 2 years,” etc. In accordance with
screening guidelines, a dummy variable was created for mammogram utilization equal to
1 if the test was taken within 1 to 2 years, and a dummy variable for pap test utilization
equals to 1 if the test was taken within 1 to 3 years.
Statistical analysis
Univariate analyses will be done to produce descriptive statistics of women’s
characteristics before and after the implementation of ACA in the sample. The main
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statistical modeling will be based on a regression equation explaining the variability of
the dependent variables in pre-ACA period using a number of determinants or
explanatory variables. The equations estimated can be written as:
𝑌𝑖0 = 𝛽0 + ∑ 𝛽𝑗 𝑋𝑖𝑗0, where Yio is the value of dependent variable for individual i
for the pre-ACA year 0 and [Xj] is a set of potential determinants of Y. This estimated
model was then used to predict the dependent variable for the post-ACA years using the
values of determinants in the post-ACA data set. In other words, we have predicted the
values of Y for the post-ACA year t using the estimates of b from the pre-ACA year.
̂0 + ∑ 𝛽̂𝑗 𝑋𝑖𝑗𝑡
𝑌𝑖𝑡 = 𝛽
The estimated coefficients b obtained for pre-ACA year will be used to predict the
values of dependent variable for individuals in post-ACA year, the year t. Another
regression model was estimated to predict the values of Y in post-ACA year using postACA data. The effect of ACA will be estimated as the value of dependent variable in the
post-ACA year minus the predicted value of the dependent variable in the post-ACA year
using the regression model obtained using pre-ACA year (the counterfactual). A positive
difference means that women in post-ACA used more mammography and pap tests
compared to pre-ACA year given various determinants of the dependent variable. Since a
number of potential determinants of dependent variable may be affected by the
introduction of ACA-triggered changes, these variables should be kept constant at the
pre-ACA level. These variables are related with insurance coverage and types of
insurance under which the individuals are covered. We have kept the values of these
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determinants constant in relative terms at the pre-ACA level by changing the sampling
weights proportionately.
To assess the diagnostic/predictive accuracy of our logistic model, we used the
area under the ROC curve measure. Third, we regressed the difference of the dependent
variable, the estimated effect of ACA adoption, on some population characteristics to
examine how different individual characteristics affect the outcome. Differences were
considered statistically significant if P-value of the t-statistics <0.05. All statistical
analysis will be carried out using STATA software version 14 (2015; Stata 14.0
Statistical Software, College Station, TX, USA The analyses accounted for probability
weighting in the MEPS (99,100).
Results
Table 5.1 shows descriptive statistics of the women’s characteristics in pre and
post ACA. Women in pre-ACA and post-ACA seem to have similar distribution of the
demographic characteristics including age, income, education, race, and insurance status,
and the availability of usual source of care (Table 5.1). Figure 5.2 shows the results from
the area under the ROC curve measure for our estimation models which indicate that both
estimating models had an area under the curve was above 74%. Tables 5.2 shows the
counterfactual analysis results which found that the utilization of mammogram and pap
test did not increase following the ACA. Women in post-ACA used less mammography
and pap tests than the same period post-ACA counterfactual (Table 5.2). The difference
for mammography is -2.31 and for pap test is -5.65 (Table 5.2). Table 5.3 and 5.4 breaks
down those differences by age, race, income, education, and health insurance type. A
positive difference indicates that this particular group decreases the difference while a
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negative difference indicate that this particular group increases the difference. For most
categories, the difference was negative except for women aged 50-64 and women with
public insurance the difference was positive which means that women in post-ACA aged
50-64 or have public insurance used more mammogram and pap test than those in preACA (Table 5.3). Similarly, women in post-ACA used less pap tests in all sub-groups
when compared to the same period post-ACA counterfactual (Table 5.4). Table 5.5
shows that difference in probabilities was statistically significant.
Discussion
Because cost-sharing was found reducing the use of medical care services,
particularly preventive care services, the ACA required private health insurers and
Medicaid to cover preventive screenings recommended by the USPSTF without costsharing to increase the use of these services. This study used a counterfactual analysis to
try to understand if the ACA’s cost-sharing provisions impacted mammograms and Pap
tests rates. In the years preceding the ACA, there was a trend of decline in both
mammogram and Pap test use among women in the U.S. (103). Our results show that the
introduction of free preventive services did not change the overall declines in
mammograms and Pap tests. These results are consistent with previous studies that found
little impact of the cost-sharing provision on mammography and pap tests rates. For
example, Hong et al. (94) found decreased rates of being up-to-date on mammograms and
Pap tests among those with private insurance after the ACA. Several other studies
examined the initial impact of the removing cost-sharing on privately insured women and
found no change in mammography and pap test (88–90). Our results show no impact on
mammography use among women with Medicare (Table 5.3). Previous studies that
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looked at Medicare population gave mixed results regarding mammography utilization
after the ACA. For example, Jensen et al. (92) found minimal change in mammography
use among older women, while other studies found statistically significant increase in
mammography uptake after the ACA (86,87). Our analysis show positive results in
mammogram rates for women aged 50-64 (Table 5.3). This is consistent a previous study
that that assessed the policy from a health system level and found the ACA provisions
were associated with increased screening volumes among women age 50-74 (93). There
is evidence that mammogram decrease breast cancer mortality among women aged 50-69
but the benefit of mammography for women aged 40-49 years is uncertain (22,23). Our
results show that younger women used more Pap tests than older women (Table 5.4).
This is consistent with the guidelines and the evidence suggesting benefits from Pap tests
are more evident for younger women (127). Our results show that black women had the
lowest decline in mammography and women from other minorities had the lowest decline
Pap test use as compared to white women (Table 5.3 and Table 5.4). A recent study
found the ACA provision to be associated with improved mammography and pap tests
among Hispanics and African Americans (95). Looking at overall utilization, black
women had the highest rate of mammogram and pap tests use (mammogram: 81.48%,
pap tests: 74.73%) (Table 5.3 and Table 5.4). Evidence show that black women in the
U.S. are more likely to diagnosed and die from breast and cervical cancer as compared to
white women, which may explain the increased use of screenings among this group
(128,133).
There are some possible explanations for the little impact of the ACA cost-sharing
provision on improving the declining rates of mammography and pap tests. First, it is
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important to recognize that the ACA cost-sharing provision was found to be effective in
improving other kind of preventive services such as blood pressure check, cholesterol
check, and flu vaccination, but not cancer screenings (134). This is probably because the
guidelines for mammograms and Pap tests were updated around the time of the ACA’s
provisions. The guidelines for mammograms were updated in 2009 to recommend
mammograms for women aged 50-75 every 2 years updating the previous guidelines that
recommends screening every 1-2 for women aged 40 and older. The guidelines for
cervical cancer screenings was updated in 2012 to recommend the Pap test for women
aged 21-65 every three years updating the previous guidelines that recommended
screening annually for women who are sexually active. These guidelines updates that
occurred around the same time as the ACA provisions may have led to overall declines in
cancer screenings. In addition to the changing guidelines, the very nature of
mammograms and Pap tests that some women find toxic or painful may discourage them
from getting the tests (119–122). Sometimes mammograms find false positives that carry
risks including pain, anxiety, and other side effects. Similar to mammograms, Pap tests
may come with harm when abnormal results lead to vaginal bleeding, pain, infection, and
anxiety. Physicians make trade-offs between benefits and risks when making
recommendations about who should be screened.
Second, the impact of removing cost-sharing may have been alleviated because
mammography and Pap tests were likely to be covered by some private insurance plans
with no or minimal cost-sharing before ACA. The amount of cost-sharing under
Medicare was also small (20% cost sharing). Also, women were likely to get the
screenings through national programs such as CDC’s National Breast and Cervical
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Cancer Early Detection Program (BCCEDP). The program was established in 1990 to
provide free and/or reduced cost mammograms and pap test to women with limited
incomes and those who lack health insurance. The program remained providing large
number of screenings to women in the years following the ACA (135).
Third, in the years before the ACA, women who are low-income were less likely
to receive possibly lifesaving recommended cancer screenings (35). A new study found
that the ACA was associated with improvements in health care-related financial strain
(136). However, socioeconomic disparities remained in term of mammograms and Pap
tests utilization. In our cohort, the majority of screenings occurred among the highincome high-educated women (Table 5.3 and Table 5.4). This is probably due to better
health literacy, awareness, and availability of time and transportation. Our analysis show
that the proportion of women who reported having a usual source of care used more
mammogram and Pap tests than those with no usual source of care (Table 5.3 and Table
5.4). Therefore, factors related to provider availability and access may be more effective
in improving utilization rates.
Finally, it is important to recognize that, although screening numbers did not
improve following the ACA, disease burden from breast and cervical cancer has been
declined over the years. Breast cancer rates have been declining steadily in the past
decade. Similarly, cervical cancer cases have declined rapidly in past 40 years due to
wide use of Pap tests, however, declines in cervical cancer cases have slowed down in
recent years.
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Conclusion
Following the removal of cost-sharing under the ACA, no improvement was
observed in mammography or pap tests rate. It is important to recognize that rates of
mammograms and Pap tests were already in a declining trend in the years before the
ACA. The introduction of the ACA provision did not help change the decline. The
rationale behind the ACA was built on the notion that cost-sharing hinders the use of
preventive care services. Several post-ACA studies found positive impact on certain kind
of preventive care services such as blood pressure check, cholesterol check, and flu
vaccination, but not cancer screenings. In the discussion section above we provided some
possible explanation for the lack of impact of cost-sharing removal provision on
mammograms and Pap tests rates.
It appears that financial barrier was not the most important factor in affecting
utilization of these screening tests. The results indicate - as well as previous studies - that
the higher level of utilization rates are observed among the wealthiest and most educated
women even after the services became free after the policy change. Therefore, policy
makers should focus efforts on facilitating access, health promotion, and awareness
which may help improve screening rates. Future research is recommended to look at
indicators of access to care, provider availability and characteristics, physician
compliance to guidelines to better understand the reasons for lack of effects of cost
reductions on utilization of cancer screenings.
We acknowledge several limitations of this study. First, information about
outcomes relied on self-reported survey responses which might be subject to recall error.
However, the MEPS follow up with health providers to reduce measurement errors but
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some errors may remain, especially for procedures and tests requiring longer recall.
Second, the data used in the analysis are cross-sectional and comparison of crosssectional data of different years is not same as observing changes in the outcomes of the
same set of individuals over the years with the implementation of the ACA. The study
design made an attempt to tease-out the effect of policy changes. Third, a longer time
frame may be needed to be able to see the effects of the policy changes on these
outcomes. Fourth, for the privately insured population, there is no information on the
coverage of screenings as health plans that were grandfathered were not subject to the
ACA provision. Because the elimination of cost-sharing is not universal for the privately
insured, full effect of removal of cost sharing will not be observable for this population
group.
Another important factor for the lack of positive effect of cost-sharing removal
may be due to changes in the USPSTF guidelines for breast cancer and cervical screening
that occurred around the same time as the ACA provisions. The change in the guidelines
may have led to overall declines in cancer screening. In 2009 the guidelines for breast
cancer screenings was updated to recommend biennial screening instead of every 1-2
years. Also, in 2012 the USPSTF guidelines for cervical cancer was updated to
recommend the test every 3 years instead of every year. If the physicians start using the
new guidelines, mammogram and Pap test screenings may appear lower if prior guideline
based utilization rates are calculated and compared. Counterfactual analysis will not be
able to correct for the changes in screening guidelines unless a control group can be
identified for comparative purposes.
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In any case, the analysis raises the concern that implementation of ACA’s cost
share removal has not been effective in improving cancer screening rates and longitudinal
survey data would be needed to understand why the removal of out of pocket costs failed
to show the intended effects. Unfortunately, the data we have are repeated crosssectional. Longitudinal data covering a period of four to five years are not available to
conduct an analysis to find out how the utilization of cancer screening tests changed for
the same individual over the years.
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Figure 5.1 Inclusion and exclusion criteria flow chart
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Figure 5.2 Area under the ROC curve for the estimating models

Table 5.1 Descriptive statistics of the characteristics of women aged >= 21 in pre-ACA
(2009) and post-ACA (2016), MEPS database
Pre-ACA
n = 13,146
%
47
68
21
9
21
31
47
42
29
27
57
24
18
77
22

Characteristics
Age
Race

Education

Income

Insurance

Usual source of
care

Mean
White
Black
Other
Some school
High School
College
Low
Middle
High
Private
Public
Uninsured
Available
Not available
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Post-ACA
n = 12,786
%
48
68
20
11
19
29
50
42
27
29
57
30
11
77
22

Table 5.2 The difference in mammography and Pap tests use between post-ACA and
post-ACA counterfactual
Post-ACA
counterfactual

Post-ACA

Difference

Predicting probabilities using 2009
model

Predicting probabilities using 2016
model

Mammogram

71.67%

69.36 %

-2.31

Pap test

79.42%

73.77%

-5.65

Table 5.3 The difference in mammography use between post-ACA and post-ACA
counterfactual, by different population groups
Category

Post-ACA
counterfactual

Post-ACA

Difference

Predicting probabilities using
2009 model

Predicting probabilities using
2016 model

Low income

62.29%

60.62%

-1.67

Middle income

71.15%

69.82%

-1.33

High income

82.40%

78.56%

-3.84

Some school

60.61%

57.23%

-3.38

High school

68.31%

68.08%

-0.23

College

78.33%

75.21%

-3.12

White

70.56%

68.46%

-2.1

Black

76.24%

74.73%

-1.51

Other

70.73%

65.57%

-5.16

40-49

65.50%

60.96%

-4.54

50-64

74.98%

75.52%

+0.54

>=65

72.49%

69.38%

-3.11

Private insurance

77.70%

74.92%

-2.78

Public insurance

66.64%

66.70%

+0.06

Uninsured

42.75%

39.50%

-3.25

Available USC

76.03%

72.82%

-3.21

Not available USC

45.33%

49.96%

-4.63
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Table 5.4 The difference in Pap tests use between post-ACA and post-ACA
counterfactual, by different population groups
Category

Post-ACA
counterfactual

Post-ACA

Difference

Predicting probabilities using
2009 model

Predicting probabilities using
2016 model

Low income

76.24%

70.22%

-6.05

Middle income

78.52%

72.68%

-5.84

High income

84.85%

79.92%

-4.93

Some school

70.46%

66.56%

-3.9

High school

75.76%

69.22%

-6.54

College

84.94%

79.14%

-5.8

White

78.16%

71.62%

-6.54

Black

85.32%

81.48%

-3.84

Other

76.71%

73.46%

-3.25

21-39

89.26%

86.17%

-3.09

40-49

86.04%

84.51%

-1.53

50-64

78.29%

73.74%

-4.55

Private insurance

83.52%

79.09%

-4.43

Public insurance

73.89%

65.44%

-8.45

Uninsured

73.13%

68.96%

-4.17

Available UCS

86.84%

83.77%

-3.07

Not available USC

79.18%

75.47%

-3.71
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Table 5.5 Likelihood of the difference between post-ACA and post-ACA counterfactual
to increase/decrease explained by different determinants
Category
Low income
Middle income
High income
Some school
High school
College
White
Black
Other

Difference in
mammogram
0
(.)
0.0256***
(37.05)
-0.00406***
(-5.58)
0
(.)
0.0298***
(37.44)
0.0120***
(15.32)
0
(.)
-0.0196***
(-24.37)
-0.0386***
(-38.73)

21-39
40-49
50-64
>=65
Private insurance
Public insurance
Uninsured
Cons_

0
(.)
0.0554***
(67.09)
0.0284***
(32.22)
0
(.)
0.0285***
(42.36)
-0.0279***
(-19.43)
-0.0651***
(-36.92)
6364

N
t statistics in parentheses
* p<0.05, ** p<0.01, *** p<0.001

64

Difference in Pap test
0
(.)
0.000804
(0.95)
0.0345***
(34.70)
0
(.)
-0.0204***
(-19.26)
-0.0280***
(-28.37)
0
(.)
0.0249***
(33.66)
0.0155***
(17.02)
0
(.)
0.00758***
(9.81)
-0.0303***
(-35.82)

0
(.)
-0.0187***
(-20.24)
-0.0191***
(-13.70)
-0.0149***
(-8.80)
8924

CHAPTER 6
CONCLUSION

The Patient Protection and Affordable Care Act of 2010 aimed at making health
care affordable for different sectors of the population and improving access to the needed
health care services including the use of preventive care services. Increased use of
preventive care services will in turn reduce costly events from poorly or unmanaged
chronic conditions. Among the strategies adapted by the ACA to achieve these aims; the
Medicaid coverage expansion and the removal of cost-sharing for recommended
preventive care services. To reduce the number of the uninsured population and improve
access to care among the low-income population, the ACA expanded the coverage of
Medicaid to include the entire population aged 18-64 with income below 138% of federal
poverty line (1). In the years before the ACA, most uninsured population were lowincome and therefore the Medicaid coverage expansion has the potential to improve
access for low-income population to the needed health care services. As a result of the
Medicaid coverage expansion, 11 million were newly eligible in Medicaid (43). There are
many post-ACA studies that found the expansion associated with improved coverage,
access, and affordability (61–69). In addition, the ACA required private health insurers
and Medicare to cover recommended preventive screenings without cost-sharing. In years
before the ACA, the percentage of American women who receive mammograms and pap
tests has been suboptimal (2). It has been documented in the literature that health care
coverage or cost-sharing were associated with the use of medical services including
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preventive care services (3–15). The removal of cost-sharing from recommended
preventive services has the potential to improve the use of these services. There are many
post-ACA studies that found the cost sharing provision associated with improved
preventive care use. The impact of both provisions on mammograms and Pap tests were
mixed (108–111,134,137–145).
Medicaid expansion
The difference-in-differences analysis showed that expansion of Medicaid under
the ACA was associated with increased Medicaid enrollment but did not yield near-term
improvements in the use of mammography and Pap tests among low-income women.
Although the difference-in-differences did not show improvements in mammograms and
Pap tests due to Medicaid expansion under ACA, low-income women living in expansion
states used higher level of screenings than their counterparts in non-expansion states. In
DID, lack of any positive results is due to pattern of changes happened in screening rates
in expansion and non-expansion states. In expansion states, the increase in screening rates
were either lower or negative. Since Medicaid expansion did not affect these screening
tests, policy makers need to examine other factors that may act as barriers in improving
access and utilization. Some possible explanations for this lack of impact of the Medicaid
expansion on mammograms and Pap tests are presented in chapter four but we have no
concrete evidence to conclusively say which factors have affected access to screening
tests adversely in the expansion states compared to non-expansion states. It is also
possible that a longer timeframe will be needed for a change to be manifested but this
study only looked at three years after the policy change. Future research on provider
availability and characteristics, insurance types, and geographical variations is warranted
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for a better understanding of the use of cancer screening procedures by the poor women
in the USA.
Cost-sharing removal
Following the removal of cost-sharing under the ACA, no improvement was
observed in mammography or pap tests rate. It is important to recognize that rates of
mammograms and Pap tests were already in a declining trend in the years before the
ACA. The introduction of the ACA provision did not help change the decline. The
rationale behind the ACA was built on the notion that cost-sharing hinders the use of
preventive care services. Several post-ACA studies found positive impact on certain kind
of preventive care services such as blood pressure check, cholesterol check, and flu
vaccination, but not cancer screenings. In chapter five we provided some possible
explanation for the lack of impact of cost-sharing removal provision on mammograms
and Pap tests rates.
It appears that financial barrier was not the most important factor in affecting
utilization of these screening tests. The results indicate - as well as previous studies - that
the higher level of utilization rates are observed among the wealthiest and most educated
women even after the services became free after the policy change. Therefore, policy
makers should focus efforts on facilitating access, health promotion, and awareness
which may help improve screening rates. Future research is recommended to look at
indicators of access to care, provider availability and characteristics, physician
compliance to guidelines to better understand the reasons for lack of effects of cost
reductions on utilization of cancer screenings.
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Limitations
We acknowledge some important limitations of this study. First, information
about outcomes relied on self-reported survey responses which might be subject to recall
error. However, the MEPS follow up with health providers to reduce the reporting errors
but some errors may still remain, especially for procedures and tests requiring longer
recall time frame. Second, the data used in the analysis are cross-sectional and
comparison of cross-sectional data at different years is not same as observing changes in
the outcomes with the implementation of ACA. In the Medicaid expansion study, the
design made an attempt to tease-out the effect of policy changes through DID and in most
cases DID approach can identify the effect of policy change even when the starting
characteristics of the control and intervention groups are significantly different. Third,
since repeated cross-sectional survey data were used, it was not possible to show the
pathways of outcome variation, i.e., the effect of ACA on Medicaid enrollment and effect
of Medicaid enrollment on the outcomes of interest. Fourth, there were changes in the
USPSTF guidelines for breast cancer and cervical screening that occurred around the
same time as the ACA provisions which may have led to overall declines in cancer
screening. In 2009 the guidelines for breast cancer screenings was updated to recommend
biennial screening instead of every 1-2 year screenings. Also, in 2012 the USPSTF
guidelines for cervical cancer was updated to recommend the test every 3 years instead of
every year. Fifth, national programs providing these tests to poor women may have
dampen the effect of the policy change and if the national program in post-policy change
years provided more emphasis on covering screenings in non-expansion states, it can
potentially offset any positive effects of Medicaid expansion when estimated through
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DID modeling. In any case, this lack of relative improvements in cancer screenings in the
Medicaid expansion states (compared to non-expansion states) is perplexing and would
require supplementing the national data with other program effects and other structural
differences between these two groups of states. Sixth, for the privately insured
population, there is no information on the coverage of screenings as health plans that
were grandfathered were not subject to the ACA provision. Because the elimination of
cost-sharing is not universal for the privately insured, full effect of removal of cost
sharing will not be observable for this population group. Finally, the data we have are
repeated cross-sectional. Longitudinal data covering a period of four to five years are not
available to conduct an analysis to find out how the utilization of cancer screening tests
changed for the same individual over the years.
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APPENDIX A
MEDICAID EXPANSION STATUS
State Medicaid expansion status as of September 2018 (Source: Kaiser foundation
website)
Medicaid
Expansion Status
Adapted

Did not adapt

Considering

States

Start date

Arizona, Arkansas, California, Colorado,
Connecticut, Hawaii, Illinois, Iowa, Kentucky,
Maryland, Minnesota, Nevada, New Jersey, New
Mexico, North Dakota, Ohio, Oregon, Rhode
Island, Washington, West Virginia
Michigan
New Hampshire
Pennsylvania
Indiana
Alaska
Montana
Louisiana
Virginia
Maine
Alabama, Florida, Georgia, Kansas, Mississippi,
Missouri, North Carolina, Oklahoma, South
Carolina, South
Dakota, Tennessee, Texas, Wisconsin, Wyoming
Idaho, Nebraska, Utah

Jan 2014

Apr 2014
Aug 2014
Jan 2015
Feb 2015
Sep 2015
Jan 2016
Jul 2016
Jan 2019
TBD
NA

To be
determined

States that expanded Medicaid to childless adults before 2014 (Source: Kaiser foundation
website)
Medicaid
Expansion Status

States

Start date

Income
eligible
level

Adapted before
2014

District of Columbia
Vermont
New York
Delaware
Massachusetts

Jul 2010
Jan 2011
Apr 2009
2009
Apr 2009

215%
160%
100%
100%
133%
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APPENDIX B
PARALLEL TREND TEST RESULTS
Mammogram

Pap tests
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